Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure
Teva Pharmaceuticals announces recall of two blood pressure drugs.
Overview of the FDA's Drug-Recall Process
Teva Pharma Receive Warning Letter - Parker Waichman LLP
Teva recalls one lot of leukemia med after finding particulates in vial | Fierce Pharma
RECALL ALERT: FDA Adds to List of Recalled Blood Pressure Drugs - The Diabetes Site News
Teva Recalls Blood Pressure Medication in the U.S.; Adds to Growing List | dLife
FDA found big problems a year ago at Chinese plant now recalling tainted valsartan | Fierce Pharma
Teva's troubled Godollo plant earns firm US FDA warning letter
FDA recalls blood pressure medicine due to potential cancer risk
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Stops Production At US Plant After FDA Concerns: Report
Teva Pharma Recalls One Lot Of Anagrelide Capsules
Metformin recall by FDA: What's the latest news on metformin ER?
Teva recalls 2 lots of hypertension drug on dissolution issues
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News
/cloudfront-us-east-1.images.arcpublishing.com/gray/UVAUY3N3VBKKPJZ24MSVDZL62I.png "FDA recalls blood pressure medicine due to potential cancer risk")
FDA recalls blood pressure medicine due to potential cancer risk
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Government of the Virgin Islands - High Blood Pressure Treatment Drug Valsartan Recalled Healthcare professionals and patients are being advised of a voluntary recall of products containing the active pharmaceutical ingredient (API)
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure | FDA
2 high blood pressure medications added to recall of heart drug - ABC News
